Cytosorbents
CTSO
#9896
Rank
S$51.92 M
Marketcap
S$0.83
Share price
-0.74%
Change (1 day)
-29.44%
Change (1 year)

Earnings for Cytosorbents (CTSO)

Earnings in 2025 (TTM): -S$17.14 Million

According to Cytosorbents's latest financial reports the company's current earnings are S$36.97 Million. In 2024 the company made an earning of -S$29.36 Million, an increase over its 2023 earnings that were of -S$37.88 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cytosorbents from 2006 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -S$17.14 Million-41.63%
2024 -S$29.36 Million-22.49%
2023 -S$37.88 Million-13.52%
2022 -S$43.8 Million34.04%
2021 -S$32.68 Million182.17%
2020 -S$11.58 Million-55.97%
2019 -S$26.3 Million14.17%
2018 -S$23.04 Million95.14%
2017 -S$11.81 Million-22.32%
2016 -S$15.2 Million39.1%
2015 -S$10.93 Million-12.89%
2014 -S$12.54 Million89%
2013 -S$6.64 Million26.65%
2012 -S$5.24 Million-26.02%
2011 -S$7.09 Million-288.45%
2010 S$3.75 M-4.17%
2009 S$3.92 M-287.19%
2008 -S$2.1 Million-47.12%
2007 -S$3.97 Million41.78%
2006 -S$2.8 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Meridian Bioscience
VIVO
S$71.69 M-537.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Hologic
HOLX
S$1.03 B-6,397.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Boston Scientific
BSX
S$4.22 B-25,894.75%๐Ÿ‡บ๐Ÿ‡ธ USA